Inherited causes of exocrine pancreatic insufficiency in pediatric patients: clinical presentation and laboratory testing

Crit Rev Clin Lab Sci. 2023 Aug;60(5):366-381. doi: 10.1080/10408363.2023.2179968. Epub 2023 Mar 6.

Abstract

Pediatric patients with exocrine pancreatic insufficiency (EPI) have symptoms that include abdominal pain, weight loss or poor weight gain, malnutrition, and steatorrhea. This condition can be present at birth or develop during childhood for certain genetic disorders. Cystic fibrosis (CF) is the most prevalent disorder in which patients are screened for EPI; other disorders also are associated with pancreatic dysfunction, such as hereditary pancreatitis, Pearson syndrome, and Shwachman-Diamond syndrome. Understanding the clinical presentation and proposed pathophysiology of the pancreatic dysfunction of these disorders aids in diagnosis and treatment. Testing pancreatic function is challenging. Directly testing aspirates produced from the pancreas after stimulation is considered the gold standard, but the procedures are not standardized or widely available. Instead, indirect tests are often used in diagnosis and monitoring. Although indirect tests are more widely available and easier to perform, they have inherent limitations due to a lack of sensitivity and/or specificity for EPI.

Keywords: Exocrine pancreatic insufficiency; cystic fibrosis; fecal fat; pancreatic elastase; pediatric.

MeSH terms

  • Child
  • Cystic Fibrosis* / complications
  • Cystic Fibrosis* / diagnosis
  • Cystic Fibrosis* / genetics
  • Exocrine Pancreatic Insufficiency* / diagnosis
  • Exocrine Pancreatic Insufficiency* / genetics
  • Feces
  • Humans
  • Infant, Newborn
  • Pancreas / physiology
  • Pancreatic Elastase

Substances

  • Pancreatic Elastase